Derick Raal describes the need for the Triglyceride Forum at a time when triglycerides are increasingly recognised as an important target for reducing residual cardiovascular risk after conventional lipid lowering therapy, as well as risk of pancreatitis.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
